Sort by
Refine Your Search
-
Listed
-
Field
-
Lung cancers are caused by tobacco smoking but there is a genetic susceptibility to their development, notably through a missense mutation in the a5 nicotinic receptor gene, carried by 30
-
language courses (French/English). – Access to health and social benefits provided by the Institut Pasteur Application: The position is expected to start between January and March 2026. Applications will be
-
@pasteur.fr . Funding is available for multiple positions immediately but candidates will be encouraged and supported to apply for independent competitive grants.
-
Postdoctoral position: Developing a human lymphoid organ-on-chip to evaluate candidate mRNA vaccines
A post-doctoral position is available to develop a 3D model of a human lymph node and apply this model to preclinical vaccine evaluation. The successful applicant will join the team of Lisa
-
7 Nov 2025 Job Information Organisation/Company Institut Pasteur Department Immunology Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Positions Postdoc
-
spoken and written is required The candidat must have a PhD in computer science, machine learning, or computational biology The position is available immediately and will remain open until filled
-
analysis The position is available starting immediately. Benefits include comprehensive healthcare coverage and 6 weeks paid annual leave. Research will be conducted at Institut Pasteur in the center
-
Your Privacy When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and
-
Send your CV along with a motivation letter to chloe.lehoucq@pasteur.fr with benjamin.devauchelle@pasteur.fr in Cc. The candidate should have a PhD in Neuroscience or Cognitive science and the
-
Post-doctoral Research Opportunity in NeuroVirology at the Institut Pasteur, Paris, France A post-doctoral potition is available in the research team of Dr Guilherme Dias de Melo in the Lyssavirus